Abstract: An isolated and purified lactic acid bacteria is provided, which is Lactobacillus paracasei PS23 (PS23) and its applications in delaying aging process, improving immunomodulatory activity, reducing, preventing or treating allergic and inflammation, preventing or treating a chronic disorder and/or (vi) preventing and/or treating a mood disorder or a neurological condition.

Abstract: Container data sharing is provided. A second container of a cluster of containers is started to process a service request in response to detecting a failure of a first container processing the service request. The service request and data generated by the first container that failed stored on a physical external memory device is accessed. The service request and the data generated by the first container that failed is loaded on the second container from the physical external memory device via a dedicated hardware link for high-speed container failure recovery.

Abstract: A method for relieving memory dysfunction using Puerariae Radix Extract is provided, including decocting Puerariae Radix in water, concentrating the extracted product thereof, and administrating an effective dose of the Puerariae Radix extract to a subject. Since the present invention merely uses Puerariae Radix as an ingredient, it belongs to a Chinese herbal medicine of single drug prescription. Further, with the same amount of Puerarin, Puerariae Radix Extract of the present invention provides a better neuroprotective effect in comparison with Puerarin, which indicates that the Puerariae Radix extract contains more active neurotrophic ingredients other than Puerarin. Therefore, Puerariae Radix extract is more promising potential therapeutic medicine than Puerarin for relieving the symptoms of anxiety and cognitive impairment.

Abstract: A Garcinia mangostana composition, a medication and a health food including the same for enhancing learning ability and memory of a patient with Alzheimer's disease are provided. The Garcinia mangostana composition includes G. mangostana and P. quinquefolius. The net weight ratio of the G. mangostana to the P. quinquefolius ranges from 4:1 to 1:16. A total of 4.5 to 35 mg of G. mangostana is per kilogram bodyweight applied, and 9 to 70 mg of P. quinquefolius per kilogram bodyweight is applied. The G. mangostana composition is capable of reducing the neuronal cell death and increasing the neurite length of the subjects with Alzheimer's disease, as well as improving the short term memory and the long term memory of the test subjects.

Abstract: A method for enhancing learning ability and memory of patients with Alzheimer's disease using mocetinostat is provided. The method includes administering an effective dose of mocetinostat into a subject in need. Based on the administration of mocetinostat, A? accumulation, Tau protein phosphorylation, and neuroinflammation can be reduced, and the level of synaptophysin and numbers of serotonergic neuron can be increased. Hence, the damage caused by the injection of oligomeric A?25-35 within hippocampal CA1 is relieved. The method may be a potential solution for relieving the symptoms of anxiety and cognitive impairment.

Abstract: A method for relieving memory dysfunction using Puerariae Radix Extract is provided, including decocting Puerariae Radix in water, concentrating the extracted product thereof, and administrating an effective dose of the Puerariae Radix extract to a subject. Since the present invention merely uses Puerariae Radix as an ingredient, it belongs to a Chinese herbal medicine of single drug prescription. Further, with the same amount of Puerarin, Puerariae Radix Extract of the present invention provides a better neuroprotective effect in comparison with Puerarin, which indicates that the Puerariae Radix extract contains more active neurotrophic ingredients other than Puerarin. Therefore, Puerariae Radix extract is more promising potential therapeutic medicine than Puerarin for relieving the symptoms of anxiety and cognitive impairment.

Abstract: A method for treating a tau-associated disease is disclosed, which comprises the step of administering a pharmaceutical composition to a subject in need. Particularly, a method for treating Alzheimer's disease is disclosed, which comprises the step of administering a pharmaceutical composition to a subject in need.

Abstract: A polyimide metal laminated plate has a first metallic film, a first thermoplastic polyimide film laminated on a surface of the first metallic film, a first thermosetting polyimide film laminated on a surface of the first thermoplastic polyimide film distal from the first metallic film, and a second thermoplastic polyimide film laminated on a surface of the first thermosetting polyimide film distal from the first thermoplastic polyimide film. The polyimide metal laminated plate has no adhesive layer, so the polyimide metal laminated plate not only has good heat resistance, flame resistance, anti-chemical properties, and dimensional stability, but also meets the thinning tendency of FPCB. In addition, by the first thermosetting polyimide film and the second thermoplastic polyimide film having a water vapor transmission rate equal to or more than 170 g-?m/m2-day, the delamination and whitening of the polyimide metal laminated plate is prevented.

Abstract: A Garcinia mangostana composition, a medication and a health food including the same for enhancing learning ability and memory of a patient with Alzheimer's disease are provided. The Garcinia mangostana composition includes G. mangostana and P. quinquefolius. The net weight ratio of the G. mangostana to the P. quinquefolius ranges from 4:1 to 1:16. A total of 4.5 to 35 mg of G. mangostana is per kilogram bodyweight applied, and 9 to 70 mg of P. quinquefolius per kilogram bodyweight is applied. The G. mangostana composition is capable of reducing the neuronal cell death and increasing the neurite length of the subjects with Alzheimer's disease, as well as improving the short term memory and the long term memory of the test subjects.

Abstract: A polyimide metal laminated plate has a first metallic film, a first thermoplastic polyimide film laminated on a surface of the first metallic film, a first thermosetting polyimide film laminated on a surface of the first thermoplastic polyimide film distal from the first metallic film, and a second thermoplastic polyimide film laminated on a surface of the first thermosetting polyimide film distal from the first thermoplastic polyimide film. The polyimide metal laminated plate has no adhesive layer, so the polyimide metal laminated plate not only has good heat resistance, flame resistance, anti-chemical properties, and dimensional stability, but also meets the thinning tendency of FPCB. In addition, by the first thermosetting polyimide film and the second thermoplastic polyimide film having a water vapor transmission rate equal to or more than 170 g-?m/m2-day, the delamination and whitening of the polyimide metal laminated plate is prevented.

Abstract: A knee and elbow protector with three-dimensional design, comprising a main body and at least a size-adjustable fastener. The main body is filled with elastic and air-permeable material for protecting a knee or an elbow, and forms the three-dimensional design according to various cartoon or animal images for aesthetic consideration. The size-adjustable fastener is made of comfortable and air-permeable material, and is partly sewn to the main body for detachably fastening the main body to a knee or an elbow so that the protector can be convenient to be taken on or off.